欧戈氨酸度与产前的风险之间的剂量相关关系
1Fiona Stanley Hospital, University of Western Australia and Murdoch University, Perth, Western Australia.
Bioscience reports
|August 21, 2023
概括
高水平的欧戈氨酸可能会防止孕前. 一项研究发现,超过第90百分点的欧戈氨酸度显著降低了孕前的风险,这表明了保护值.
科学领域:
- 产科和妇科 产科和妇科
- 营养生物化学 营养生物化学
- 生殖健康 生殖健康
背景情况:
- 孕前是全世界母婴发病的主要原因之一.
- 作为一种天然存在的抗氧化剂,欧戈氨酸因其潜在的健康益处而受到研究.
- 以前的研究表明,欧戈氨酸与怀孕结果之间可能存在联系.
研究的目的:
- 调查欧戈氨酸水平与患孕前的风险之间的关联.
- 为了确定特定度的值能否提供预防先兆子的保护.
- 探索埃尔戈西欧内因与产前风险之间的非线性关系.
主要方法:
- 对一组数据集的二次分析,该数据集检查了孕妇的欧戈氨酸水平.
- 使用了单变量和多变量回归分析.
- 使用3节限立方线函数来建模非线性关联.
- 母亲年龄和体重指数被认为是共变量.
主要成果:
- 在欧戈氨酸水平和母亲年龄之间发现了微弱的关联.
- 埃尔戈西欧内因≥462ng/ml (第90百分位) 的值与显著较低的孕前发病率相关 (1%vs24.2%).
- 单变量和多变量分析表明,从300 ng/ml开始的ergothioneine的保护作用.
- 增加的体重指数与更高的孕前症风险显著相关.
结论:
- 高度的欧戈氨酸,特别是在90百分位以上,可能会对孕前有保护作用.
- 欧戈氨酸与产前风险呈现非线性关联,在≥300 ng/ml水平时观察到具有保护作用.
- 体重指数是孕前的独立风险因素.
更多相关视频
08:56Detection of Regulated Ergot Alkaloids in Food Matrices by Liquid Chromatography-Trapped Ion Mobility Spectrometry-Time-of-Flight Mass Spectrometry
Published on: November 22, 2024
686
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
15.9K
相关概念视频
01:03Dose-Response Relationship: Overview
3.2K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.2K
01:22Dose-Response Relationship: Potency and Efficacy
4.5K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.5K
01:07Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
01:21Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
01:14Time Course of Drug Effect
2.1K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.1K
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
195
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
195